CTL Medical Receives FDA 510(k) Clearance for MATISSE ACIF Cage

CTL Medical received FDA 510(k) clearance to market the MATISSE™ Titanium Anterior Cervical Interbody Fusion cage for use with supplemental fixation, such as the company’s VAN GOGH™ anterior cervical plate.

MATISSE features CTL’s proprietary TiCro™ surface technology, which is designed to offer 200% greater endplate contact surface area. The first version of MATISSE received its clearance in 2012 under AccelSPINE, which was acquired by CTL in 1Q16.

Sources: CTL Medical Corporation; ORTHOWORLD Inc.